Format
Sort by

Send to

Choose Destination

Links from Books

Items: 20

1.

Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.

Xiao J, Horst S, Hinkle G, Cao X, Kocak E, Fang J, Young D, Khazaeli M, Agnese D, Sun D, Martin E Jr.

Cancer Biother Radiopharm. 2005 Feb;20(1):16-26.

PMID:
15778575
2.

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK.

Nucl Med Biol. 2005 Feb;32(2):157-64.

PMID:
15721761
3.

99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.

Goel A, Baranowska-Kortylewicz J, Hinrichs SH, Wisecarver J, Pavlinkova G, Augustine S, Colcher D, Booth BJ, Batra SK.

J Nucl Med. 2001 Oct;42(10):1519-27.

4.

Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.

Goel A, Colcher D, Baranowska-Kortylewicz J, Augustine S, Booth BJ, Pavlinkova G, Batra SK.

Cancer Res. 2000 Dec 15;60(24):6964-71.

5.

Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.

Goel A, Beresford GW, Colcher D, Pavlinkova G, Booth BJ, Baranowska-Kortylewicz J, Batra SK.

J Biochem. 2000 May;127(5):829-36.

6.

Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.

Pavlinkova G, Beresford GW, Booth BJ, Batra SK, Colcher D.

J Nucl Med. 1999 Sep;40(9):1536-46.

7.

Effects of genetic engineering on the pharmacokinetics of antibodies.

Colcher D, Goel A, Pavlinkova G, Beresford G, Booth B, Batra SK.

Q J Nucl Med. 1999 Jun;43(2):132-9. Review.

PMID:
10429508
8.
9.

Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen.

Primus FJ, Bennett SJ, Kim EE, DeLand FH, Zahn MC, Goldenberg DM.

Cancer Res. 1980 Mar;40(3):497-501.

10.

A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

Colcher D, Hand PH, Nuti M, Schlom J.

Proc Natl Acad Sci U S A. 1981 May;78(5):3199-203.

11.

Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.

Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D.

Cancer Res. 1986 Feb;46(2):850-7.

12.

A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.

Paterson AJ, Schlom J, Sears HF, Bennett J, Colcher D.

Int J Cancer. 1986 May 15;37(5):659-66.

PMID:
3699929
13.

Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.

Colcher D, Esteban J, Carrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G, Larson SM, Schlom J.

Cancer Res. 1987 Aug 1;47(15):4218-24. Erratum in: Cancer Res 1987 Nov 15;47(22):6161.

14.

Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.

Colcher D, Minelli MF, Roselli M, Muraro R, Simpson-Milenic D, Schlom J.

Cancer Res. 1988 Aug 15;48(16):4597-603.

15.

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.

Muraro R, Kuroki M, Wunderlich D, Poole DJ, Colcher D, Thor A, Greiner JW, Simpson JF, Molinolo A, Noguchi P, et al.

Cancer Res. 1988 Aug 15;48(16):4588-96.

16.

Transport of molecules across tumor vasculature.

Jain RK.

Cancer Metastasis Rev. 1987;6(4):559-93. Review.

PMID:
3327633
17.

Single-chain antigen-binding proteins.

Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, Whitlow M.

Science. 1988 Oct 21;242(4877):423-6. Erratum in: Science 1989 Apr 28;244(4903):409.

PMID:
3140379
19.

In vivo tumor targeting of a recombinant single-chain antigen-binding protein.

Colcher D, Bird R, Roselli M, Hardman KD, Johnson S, Pope S, Dodd SW, Pantoliano MW, Milenic DE, Schlom J.

J Natl Cancer Inst. 1990 Jul 18;82(14):1191-7.

PMID:
2362290
20.

The development of new radiopharmaceuticals.

Britton KE.

Eur J Nucl Med. 1990;16(4-6):373-85. Review.

PMID:
2190837
Items per page

Supplemental Content

Support Center